Comparison of immunogenicity and reactogenicity of two trivalent influenza virus vaccines in South Korean children

Trial Profile

Comparison of immunogenicity and reactogenicity of two trivalent influenza virus vaccines in South Korean children

Completed
Phase of Trial: Phase III

Latest Information Update: 09 Dec 2011

At a glance

  • Drugs Influenza virus vaccine (Primary)
  • Indications Influenza virus infections
  • Focus Pharmacodynamics; Registrational
  • Sponsors Green Cross
  • Most Recent Events

    • 08 Dec 2011 New trial record
    • 01 Nov 2011 Results published in the Journal of Korean Medical Science.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top